Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2567924 | Pulmonary Pharmacology & Therapeutics | 2006 | 9 Pages |
Abstract
Administration of the pan-selectin antagonist bimosiamose is effective in a human allergen challenge model of asthma. The result of this proof-of-concept exploratory trial is the first study that demonstrates clinical efficacy of selectin-antagonists as novel therapeutic strategy in asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Kai M. Beeh, Jutta Beier, Michael Meyer, Roland Buhl, Rainer Zahlten, Gerhard Wolff,